CUSA-081
- Generic Name
- CUSA-081
Efficacy and Safety of CUSA-081 in the Restoration of Dysfunctional Central Venous Access Device (CVAD) Functionality
- First Posted Date
- 2019-06-20
- Last Posted Date
- 2022-04-15
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Registration Number
- NCT03992443
- Locations
- 🇧🇬
Chiesi Investigational site, Stara Zagora, Bulgaria
ðŸ‡ðŸ‡ºChiesi investigational site, Székesfehérvár, Hungary
🇧🇬Chiesi Investigational Site, Razgrad, Bulgaria
Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) Functionality
Phase 3
Terminated
- Conditions
- Catheter OcclusionThrombosis
- Interventions
- First Posted Date
- 2018-07-20
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 462
- Registration Number
- NCT03594175
- Locations
- 🇷🇴
Chiesi Invesitgational Site, Cluj-Napoca, Romania
🇺🇸Einspahr, Topeka, Kansas, United States
🇪🇸Chiesi Investigational Site, Sevilla, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath